Expression of Interleukin-5 and Tumor Necrosis Factor Alpha in Cervical Carcinoma | Zendy

Dae Woo Lee | Zendy; Young Tae Kim | Zendy; Sang Wun Kim | Zendy; Sunghoon Kim | Zendy; JaeHoon Kim | Zendy; MyungHwa Kang | Zendy; Jeong Hye Hwang | Zendy; JongBaeck Lim | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Expression of Interleukin-5 and Tumor Necrosis Factor Alpha in Cervical Carcinoma

Author(s) -

Dae Woo Lee,

Young Tae Kim,

Sang Wun Kim,

Sunghoon Kim,

JaeHoon Kim,

MyungHwa Kang,

Jeong Hye Hwang,

JongBaeck Lim

Publication year - 2009

Publication title -

clinical and vaccine immunology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.649

H-Index - 77

eISSN - 1556-6811

pISSN - 1556-679X

DOI - 10.1128/cvi.00262-08

Subject(s) - tumor necrosis factor alpha , cervical carcinoma , alpha (finance) , cancer research , interleukin , carcinoma , medicine , pathology , oncology , cervical cancer , cytokine , cancer , surgery , construct validity , patient satisfaction

Interleukin-5 (IL-5) levels were significantly higher in vaginal washing fluids from patients with cervical carcinoma than in those from patients with carcinoma in situ and controls. Tumor necrosis factor alpha levels did not differ among the three groups. Detection of IL-5 in cervical secretions may be a useful marker for evaluating aggressive local immune response in cervical carcinoma.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research